Evaluation of Serum Ages Levels in Patients With Endometriosis

Study Overview
=================
Brief Summary
-----------------
Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Detailed Description
-----------------
Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.

Official Title
-----------------
The Serum Ages Levels in Patients With Endometriosis

Conditions
-----------------
Endometriosis

Intervention / Treatment
-----------------
* Other: Advanced Glycation End Products (AGEs)


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: diagnosed with endometriosis (Surgery or ultrasound) Women without endometriosis Exclusion Criteria: Women without endometriosis women who are only suspected endometriosis

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| women with endometriosis<br>It consists of women between the ages of 18-45 who have been diagnosed with endometriosis by surgery or ultrasonography. | Other: Advanced Glycation End Products (AGEs)<br>* Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.<br>|
| control<br>It consists of healthy women between the ages of 18-45 | Other: Advanced Glycation End Products (AGEs)<br>* Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Serum Advanced Glycation End Products (AGEs) levels in women with endometriosis | Serum Serum Advanced Glycation End Products (AGEs) levels involved in inflammation and energy metabolism are compared between endometriosis and healthy control group | 8 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Comparison of the relationship between serum Serum Advanced Glycation End Products (AGEs) level and endometriosis stage | By comparing the relation of serum Advanced Glycation End Products (AGEs) level with the stage of endometriosis, its relation with serum level in patients with advanced and early stage endometriosis will be examined. The possible effect of Advanced Glycation End Products (AGEs) on disease pathogenesis will be examined. | 8 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
AGES (Advanced Glycation End Products)